Skip to content

Distal Gut Mucosal Barrier Repair: A Clinical Study of Retrograde Effluent Infusion via Double-Barreled Ileostomy

Distal Gut Mucosal Barrier Repair: A Clinical Study of Retrograde Effluent Infusion via Double-Barreled Ileostomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108665
Enrollment
Unknown
Registered
2025-09-03
Start date
2024-09-07
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Double-Barreled Ileostomy

Interventions

FMT group:On the day of intervention, collect 100 g of effluent from the proximal ileostomy, dilute it to 200–300 mL with sterile saline, and filter the mixture through two layers of sterile gauze to
Nacl group:Insert a 16-French three-lumen catheter approximately 10 cm into the distal limb of the loop stoma, inflate the balloon with 10–15 mL of sterile water, and then instill 200–300 mL of steril
Blank group:none

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients who underwent radical colectomy with terminal ileal loop stoma for malignant tumors of the left transverse colon, descending colon, sigmoid colon, and rectum. (2) Age 18–70 years. (3) BMI 18.5–23.9 kg/m². (4) Preoperative gastrointestinal contrast study and colonoscopy definitively excluding anastomotic leakage or obstruction.

Exclusion criteria

Exclusion criteria: (1) Having a history of alcohol abuse for more than 2 years and a long-term smoking history; (2) Have other metabolic diseases, such as obesity, hypertension, diabetes, calculus, various liver diseases, or have other autoimmune diseases, such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, etc; (3) Having a family history of genetics, mental illness, etc; (4) Researchers believe that other reasons are not suitable for continuing clinical trials.

Design outcomes

Primary

MeasureTime frame
intestial barrier;

Secondary

MeasureTime frame
gut microbiota;Time to first postoperative flatus;time to first postoperative bowel movement;time to first formed stool;length of postoperative hospital stay;total hospitalization cost;

Countries

China

Contacts

Public ContactQingliang He

The First Affiliated Hospital of Fujian Medical University

hydzfy@hotmail.com+86 186 0508 7939

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026